Dr. Elijah Stommel | Toxicology | Best Researcher Award
Dr. Elijah W. Stommel is a distinguished neurologist born in Hamilton, Bermuda π, currently serving as Professor of Neurology at the Geisel School of Medicine at Dartmouth π§ , renowned for his clinical expertise, pioneering ALS research, and dedication to patient-centered care π‘; his prolific academic journey, consulting roles, and leadership in rare disease research reflect decades of unwavering service to neurology π₯, academia π, and public health advocacy π§¬.
Profile
Education π
Dr. Stommel holds an M.D. (1987) and a Ph.D. in Physiology (1984) from Boston University School of Medicine π; he earned a B.A. with High Honors in Music from Bowdoin College π΅ (1977), pursued advanced coursework at MIT ποΈ, and honed his research skills as a Research Assistant at the Marine Biological Laboratory in Woods Hole π¬ β blending physiology, neurology, and music to form a truly interdisciplinary academic foundation π.
Experience π¨βπ«
With over three decades in clinical neurology π§ , Dr. Stommel progressed from Chief Resident at Dartmouth-Hitchcock (1990-91) to Professor of Neurology (2013βpresent) π¨βπ«; he has served as Staff Neurologist at Dartmouth-Hitchcock Clinic since 1991 π₯, held multiple consultant roles across Vermont and New Hampshire πΊοΈ, and co-directs the Electromyography Lab β‘, establishing himself as a trusted educator, clinician, and research mentor in both academic and hospital environments π.
Awards & Recognitions π
Dr. Stommelβs commitment to humanism and excellence in neurology earned him a nomination for the prestigious Tow Humanism in Medicine Award π (2011); he is a Fellow of the American Academy of Neurology ποΈ and holds long-standing certifications in Electrodiagnostic Medicine and Neurology π§ , complemented by leadership roles on numerous committees advancing research ethics, clinical trials, and medical education ππ‘.
Research Interests π¬
Dr. Stommelβs research revolves around neurodegenerative diseases, especially ALS π§¬, exploring environmental toxins πΏ, nanotechnology π§ͺ, and biomarkers π to advance diagnostics and therapeutics; as an active reviewer and editor for journals like Nature Nanotechnology, Frontiers in Neurology, and Molecular Neurobiology π§ , he continually shapes scientific discourse while his collaborative work with global ALS consortia helps identify novel causal pathways and treatment avenues ππ‘.